---
title: "Avantor, Inc. (AVTR.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/AVTR.US.md"
symbol: "AVTR.US"
name: "Avantor, Inc."
industry: "Life Sciences Tools and Services"
datetime: "2026-05-20T06:37:32.895Z"
locales:
  - [en](https://longbridge.com/en/quote/AVTR.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AVTR.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AVTR.US.md)
---

# Avantor, Inc. (AVTR.US)

## Company Overview

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | US Market |
| Website | [www.avantorsciences.com](https://www.avantorsciences.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: D (0.64)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 43 / 59 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -1.99% |  |
| Net Profit YoY | -177.05% |  |
| P/B Ratio | 0.93 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 5216251271.28 |  |
| Revenue | 6552200000.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -9.44% | D |
| Profit Margin | -8.42% | D |
| Gross Margin | 31.66% | C |
| Revenue YoY | -1.99% | D |
| Net Profit YoY | -177.05% | E |
| Total Assets YoY | -5.38% | D |
| Net Assets YoY | -8.35% | D |
| Cash Flow Margin | -103.95% | E |
| OCF YoY | -1.99% | D |
| Turnover | 0.55 | C |
| Gearing Ratio | 52.08% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Avantor, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-1.99%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-177.05%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.93",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "5216251271.28",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "6552200000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-9.44%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-8.42%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "31.66%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "-1.99%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-177.05%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-5.38%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-8.35%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-103.95%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-1.99%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.55",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "52.08%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -9.46 | 48/59 | 13.34 | 12.83 | 12.33 |
| PB | 0.93 | 10/59 | 1.49 | 1.40 | 1.04 |
| PS (TTM) | 0.80 | 6/59 | 1.36 | 1.21 | 0.88 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | ChromaDex (CDXC.US) | A | A | A | B | A | A |
| 02 | Agilent Tech (A.US) | A | C | B | C | C | B |
| 03 | West Pharmaceutical (WST.US) | B | B | B | B | B | B |
| 04 | Illumina (ILMN.US) | A | C | B | D | C | B |
| 05 | WuXi Biologics (WXXWY.US) | B | B | C | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-14T04:00:00.000Z

Total Analysts: **16**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 19% |
| Hold | 11 | 69% |
| Underweight | 1 | 6% |
| Sell | 1 | 6% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 7.64 |
| Highest Target | 19.00 |
| Lowest Target | 7.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/AVTR.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/AVTR.US/norm.md)
- [Related News](https://longbridge.com/en/quote/AVTR.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/AVTR.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**